LabCompass

Michele Yip-Schneider

Medicine · Indiana University

OpenAlex ORCID
Pancreatic and Hepatic Oncology ResearchEsophageal Cancer Research and TreatmentColorectal Cancer Screening and DetectionPancreatitis Pathology and TreatmentCholangiocarcinoma and Gallbladder Cancer Studies

Publications

397

Citations

4,293

Est. group size

—

Recurring co-author estimate

Active years

34

Publishing since 1993

Research summary
AI-generated

Michele Yip-Schneider studies pancreatic cancer, with a focus on detecting the disease and its precursor lesions at the earliest possible stage. Much of the work involves identifying biological markers (in blood, cyst fluid, and tissue) that signal whether growths such as intraductal papillary mucinous neoplasms are likely to become cancerous, and exploring metabolic and immune changes that could be targeted for early intervention.

Early detection of pancreatic cancerBiomarkers in blood and cyst fluidPrecancerous pancreatic lesions (IPMN)Cancer metabolism and lipidomicsTumor immune surveillance

Output was modest and steady through the late 2010s (roughly 9-14 per year) and then spiked dramatically from 2023 onward, likely reflecting large collaborative studies with many associated data records.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 56.6/year recently
2017: 9 publications172018: 10 publications182019: 14 publications192020: 12 publications202021: 5 publications212022: 5 publications222023: 166 publications166232024: 59 publications242025: 52 publications252026: 1 publication26
Recent publications
Publishes in
  • Cancer Research×7
  • HPB×5
  • Gastroenterology×4
  • PMC×4
  • Clinical Cancer Research×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile